期刊文献+

H型高血压合并射血分数保留心力衰竭患者血清NT-pro BNP、hs-CRP、BUA、Hcy临床意义研究 被引量:16

Clinical Significance of Serum NT-pro BNP,hs-CRP,BUA and Hcy in Patients with H-type Hypertension Complicated with Ejection Fraction Preserving Heart Failure
原文传递
导出
摘要 目的:探讨H型高血压合并射血分数保留心力衰竭(HFpEF)患者血清N端脑钠肽前体(NT-pro BNP)、超敏C-反应蛋白(hs-CRP)、尿素氮(BUA)、同型半胱氨酸(Hcy)的表达特点及临床意义。方法:选取本院2015年1月~2019年1月期间收治的200例H型高血压合并HFpEF患者,记为观察组;选取同期收治的60例单纯H型高血压患者,记为对照组。检测并比较两组血清NT-pro BNP、hs-CRP、BUA、HCY表达水平。根据纽约心功能分级(NYHA)将观察组分为Ⅱ~Ⅳ亚组,比较各亚组间血清NT-pro BNP、hs-CRP、BUA、Hcy和超声心动图相关指标差异,并分析上述标间表达的相关性。结果:观察组血清NT-pro BNP、hs-CRP、BUA、Hcy水平均高于对照组,HFpEF患者上述指标检测水平以及超声心动图指标LVDd、IVST、LAV随NYHA分级增加而升高,LVEF随NYHA分级增加而下降,亚组间比较差异均有统计学意义;Pearson相关性分析显示,HFpEF患者上述血清指标和LVEF均呈负相关(r=-0.753、-0.421、-0.537、-0.628),血清NT-pro BNP与hs-CRP、BUA、Hcy均呈正相关(r=0.423、0.457、0.628)。结论:H型高血压合并HFpEF患者血清NT-pro BNP、hs-CRP、BUA、Hcy水平明显升高,且检测水平和NYHA分级、LVEF存在紧密关联,临床加强检测对优化HFpEF诊断及病情程度评估具有重要价值。 Objective To investigate the expression and clinical significance of N-terminal brain natriuretic peptide precursor(NT-pro BNP),hypersensitive C-reactive protein(hs-CRP),urea nitrogen(BUA)and homocysteine(Hcy)in patients with H-type hypertension complicated with ejection fraction preserved heart failure(HFpEF).Methods 200 patients with H-type hypertension and HFpEF admitted in our hospital from January 2015 to January 2019 were selected as observation group,and 60 patients with simple H-type hypertension admitted in the same period were selected as control group.The serum levels of NT-pro BNP,hs-CRP,BUA and HCY were detected and compared between the two groups.According to New York Heart Function Classification(NYHA),the observation group was divided into subgroups II to IV.The differences of serum NT-pro BNP,hs-CRP,BUA,Hcy and echocardiographic related indicators were compared among subgroups,and the correlation between the above-mentioned indicators was analyzed.Results The serum levels of NT-pro BNP,hs-CRP,BUA and Hcy in the observation group were higher than those in the control group.The detection level of above-mentioned indexes and echocardiographic indexes LVDd,IVST and LAV in HFpEF patients increased with the increase of NYHA grade,while LVEF decreased with the increase of NYHA grade.There were significant differences between the subgroups.Pearson correlation analysis showed that the above-mentioned blood levels in HFpEF patients had statistical significance.The serum NT-pro BNP was positively correlated with hs-CRP,BUA and Hcy(r=0.423,0.457,0.628).Conclusion The serum levels of NT-pro BNP,hs-CRP,BUA and Hcy in patients with H-type hypertension complicated with HFpEF were significantly increased,and there was a close correlation between the detection level and NYHA classification and LVEF.Strengthening the clinical detection was of great value in optimizing the diagnosis of HFpEF and evaluating the severity of HFpEF.
作者 宋婷婷 刘丽 付志强 贾红丹 Song Ting-ting;Liu Li;Fu Zhi-qiang;Jia Hong-dan(Qinhuangdao First Hospital,Qinhuangdao 066000,China)
出处 《湖南师范大学学报(医学版)》 2020年第2期37-40,共4页 Journal of Hunan Normal University(Medical Sciences)
基金 H型高血压合并射血分数保留心衰患者的临床研究(201805A046).
关键词 H型高血压 射血分数保留心力衰竭 N端脑钠肽前体 超敏C-反应蛋白 尿素氮 同型半胱氨酸 h-type hypertension ejection fraction retention heart failure n-terminal brain natriuretic peptide precursor hypersensitive c-reactive protein urea nitrogen homocysteine
  • 相关文献

参考文献16

二级参考文献155

  • 1俞羚,董荃,宋叶平,江静雯,李卉,刘亮贤,苏爱萍,李焰生,Sacco RL,Kasner SE,Broderick JP,Caplan LR,Connors JJ,Culebras A,Elkind MS,George MG,Hamdan AD,Higashida RT,Hoh BL,Janis LS,Kase CS,Kleindorfer DO,Lee JM,Moseley ME,Peterson ED,Turan TN,Valderrama AL,Vinters HV.面向21世纪的卒中新定义:美国心脏病学会和美国卒中学会声明[J].神经病学与神经康复学杂志,2013,10(2):105-120. 被引量:192
  • 2张素荣,陈志刚,吕风华,张永春,李红军,袁宇,黄陆力,张卫国,桑文风.冠心病和高血压血浆同型半胱氨酸及内皮素的变化[J].中国危重病急救医学,2005,17(5):309-309. 被引量:18
  • 3王桂红,王拥军,何耀,姜卫剑,杜彬,金旻.血浆同型半胱氨酸水平与脑大动脉粥样硬化性病变的相关性分析[J].中华内科杂志,2006,45(9):744-747. 被引量:30
  • 4李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:386
  • 5Kannel WB, Castelli WP, McNamara PM, et al. Role of blood pressure in the development of congestive heart failure--the Framingham study [ J ]. N Engl J Med, 1972,287:781-787.
  • 6Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure [ J ]. JAMA, 1996,275 (20) : 1557 -1562.
  • 7Hsia J, Margolis KL, Eaton CB, et al. Prehyperteasion and cardiovascular disz ease risk in the Women' s Health Initiative[J]. Cireulation,2007,115(7) :855- 860,.
  • 8Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with vari- ous antihypertensive therapies used as first-line agents:a network meta-analysis [ J ]. JAMA,2003,289 (19) :2534-2544.
  • 9Nigel S, Beckett NS, Ruth PR, et al. Treatment of hypertension in patients 80 years age or older[J]. N Engl J Med,2008,358:1887-1898.
  • 10McMurray J J, Adamopeulos S, Anker SD, et al. ESC Guidelines for the diagno- sis and treatment of acute and chronic heart failure 2012:the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Associa- tion(HFA) of the ESC[ J ]. Eur Heart J ,2012,33 (14) : 1787-1847.

共引文献489

同被引文献223

引证文献16

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部